We sought to harvest the statistical power of the Pan-Cancer technique on a large number of clinical samples to explore the relationship between NOX4 and p53 in the context of various genetic programs of cancer progression, i.e., EMT, cell migration, proliferation, angiogenesis, along with clinical outcomes. The gene discussed is TP53; the disease is cancer.